Company / FCF Margin
NewAmsterdam Pharma Co N.V. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-657.8%
FY2025
5-year range
-1002.4% / 10.2%
FY2022-FY2025
Trend
-88.2%
vs FY2024
Sector context
#116 of 134
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s fcf margin of -657.8% is lower than 87% of companies in the Health Care sector (FY2025). Improved from -1002.4% to -657.8% over the past 2 years.
Based on SEC 10-K filings.
-657.8% in FY2025 with a 3-year CAGR of -668.0%.
Improved from -1002.4% to -657.8% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -668.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 134This company -657.8% Sector average -637.8%
▼
-3.1% below sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 88.2% year-over-year.
- Currently 20.0pp below the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -657.8% | -88.2% |
| FY2024 | -349.5% | +65.1% |
| FY2023 | -1002.4% | -9956.7% |
| FY2022 | 10.2% | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026